BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3480539)

  • 1. Unexpected binding of an octapeptide to the angiotensin II receptor.
    Soffer RL; Bandyopadhyay S; Rosenberg E; Hoeprich P; Teitelbaum A; Brunck T; Colby CB; Gloff C
    Proc Natl Acad Sci U S A; 1987 Dec; 84(24):9219-22. PubMed ID: 3480539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A specific binding site recognizing a fragment of angiotensin II in bovine adrenal cortex membranes.
    Bernier SG; Fournier A; Guillemette G
    Eur J Pharmacol; 1994 Dec; 271(1):55-63. PubMed ID: 7698212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A soluble angiotensin II-binding protein from rabbit liver.
    Rosenberg E; Ravi Kiron MA; Soffer RL
    Biochem Biophys Res Commun; 1988 Feb; 151(1):466-72. PubMed ID: 3348788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective peptide and nonpeptide ligands differentially bind to angiotensin II AT2 receptor and a non-angiotensin II CGP42112 binding site.
    Ciuffo GM; Saavedra JM
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1129-34. PubMed ID: 7562479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological activity of angiotensin II analogues containing a Val-His replacement, Val psi[CH(CONH2)NH]His.
    Mohan R; Chou YL; Bihovsky R; Lumma WC; Erhardt PW; Shaw KJ
    J Med Chem; 1991 Aug; 34(8):2402-10. PubMed ID: 1875337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a specific binding site for angiotensin II in chicken liver.
    Bouley R; Gosselin M; Plante H; Servant G; Pérodin J; Arcand M; Guillemette G; Escher E
    Can J Physiol Pharmacol; 1997 Jun; 75(6):568-75. PubMed ID: 9276130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of angiotensin II receptor subtypes in rabbit ventricular myocardium.
    Rogg H; Schmid A; de Gasparo M
    Biochem Biophys Res Commun; 1990 Nov; 173(1):416-22. PubMed ID: 2256931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of complementary peptides in the purification of an angiotensin II binding protein.
    Elton TS; Oparil S; Blalock JE
    J Hypertens Suppl; 1988 Dec; 6(4):S404-7. PubMed ID: 3241229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of essential disulfide bonds in angiotensin II binding sites of rabbit hepatic membranes. Inactivation by dithiothreitol.
    Sen I
    Biochim Biophys Acta; 1985 Feb; 813(1):103-10. PubMed ID: 3970913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of an angiotensin II-binding protein from liver.
    Sen I; Bull HG; Soffer RL
    Proc Natl Acad Sci U S A; 1984 Mar; 81(6):1679-83. PubMed ID: 6324211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies defining minimal receptor domains for angiotensin II.
    Pendleton RG; Gessner G; Horner E
    J Pharmacol Exp Ther; 1989 Jul; 250(1):31-6. PubMed ID: 2746504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational analysis of the interaction of the N- and C-terminal ends of angiotensin II with the rat AT(1A) receptor.
    Costa-Neto CM; Miyakawa AA; Oliveira L; Hjorth SA; Schwartz TW; Paiva AC
    Br J Pharmacol; 2000 Jul; 130(6):1263-8. PubMed ID: 10903964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rabbit renal epithelial angiotensin II receptors.
    Dulin NO; Ernsberger P; Suciu DJ; Douglas JG
    Am J Physiol; 1994 Nov; 267(5 Pt 2):F776-82. PubMed ID: 7977780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple binding modes for the receptor-bound conformations of cyclic AII agonists.
    Plucinska K; Kataoka T; Yodo M; Cody WL; He JX; Humblet C; Lu GH; Lunney E; Major TC; Panek RL
    J Med Chem; 1993 Jun; 36(13):1902-13. PubMed ID: 8515427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cu(II) binding by angiotensin II fragments: Asp-Arg-Val-Tyr-Ile-His and Arg-Val-Tyr-Ile-His. Competition between amino group and imidazole nitrogens in anchoring of metal ions.
    Bal W; Jezowska-Bojczuk M; Kozlowski H; Chruscinski L; Kupryszewski G; Witczuk B
    J Inorg Biochem; 1995 Mar; 57(4):235-47. PubMed ID: 7775978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The globin fragment LVV-hemorphin-7 is an endogenous ligand for the AT4 receptor in the brain.
    Moeller I; Lew RA; Mendelsohn FA; Smith AI; Brennan ME; Tetaz TJ; Chai SY
    J Neurochem; 1997 Jun; 68(6):2530-7. PubMed ID: 9166749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for agonist-induced interaction of angiotensin receptor with a guanine nucleotide-binding protein in bovine adrenal zona glomerulosa.
    De Léan A; Ong H; Gutkowska J; Schiller PW; McNicoll N
    Mol Pharmacol; 1984 Nov; 26(3):498-508. PubMed ID: 6092899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the His273 located in the sixth transmembrane domain of the angiotensin II receptor subtype AT2 in ligand-receptor interaction.
    Turner CA; Cooper S; Pulakat L
    Biochem Biophys Res Commun; 1999 Apr; 257(3):704-7. PubMed ID: 10208847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation of Asp74 of the rat angiotensin II receptor confers changes in antagonist affinities and abolishes G-protein coupling.
    Bihoreau C; Monnot C; Davies E; Teutsch B; Bernstein KE; Corvol P; Clauser E
    Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5133-7. PubMed ID: 8506360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of platelet function with synthetic peptides designed to be high-affinity antagonists of fibrinogen binding to platelets.
    Ruggeri ZM; Houghten RA; Russell SR; Zimmerman TS
    Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5708-12. PubMed ID: 3016716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.